Merck will acquire Imago BioSciences, a pharmaceutical company that focuses on treatments for bone marrow diseases, for $1.35 billion, the drugmaker said Nov. 21. 

The nation's first drug approved to delay the onset of stage 3 Type 1 diabetes is expected to cost $13,850 per vial, the drugmaker said Nov. 18. 

Teva Pharmaceuticals named Richard Francis as its next president and CEO, effective Jan. 1. 

Among three drugmakers, 29 amoxicillin and clavulanate oral presentations are on allocation or back order, according to the American Society of Health-System Pharmacists. 

Rite Aid has paired up with Grubhub to deliver over-the-counter drugs and other products, the retail chain said Nov. 17. 

In a win for Red Bank, N.J.-based ProventionBio, the FDA approved its drug Tzield Nov. 17, marking the first approved therapy to delay the onset of Type 1 diabetes. 

Oklahoma regulators proposed the nation's first detailed rule regarding temperature control while shipping medications, NBC News reported Nov. 17.

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Three members of the House of Representatives proposed legislation for new drugs to go through an independent value assessment to determine a fair price, which the lawmakers said would complement the recently passed Inflation Reduction Act. 

As the team of 33 at Mark Cuban Cost Plus Drug Co. works to serve its 1.3 million customers, Mr. Cuban told Time his planned next steps for the company that looks to disrupt the $1.4 trillion pharmaceutical industry. 

A prescription drug intended to help people with diabetes and help with long-term weight management is experiencing shortages because of its popularization as a weight loss drug on TikTok. 

OptrumRx, UnitedHealth's pharmacy benefit manager, will keep AbbVie's best-selling rheumatoid arthritis drug Humira on its formulary in 2023 alongside three competing biosimilar versions set to debut next year, Bloomberg reported Nov. 15.

Baptist Health South Florida is the first health system in the nation to hire clinical wellness pharmacists, the 11-hospital system said Nov. 15. 

The average 340B safety-net hospital, which cares for a disproportionate share of low-income and uninsured patients, reported annual losses of $2.96 million, and the average critical access hospital lost an average of $507,000 as a result of drug company 340B restrictions, according to a survey conducted by the American Hospital Association. 

CVS began allowing its pharmacists to prescribe Pfizer's COVID-19 antiviral treatment Nov. 15, more than five months after the FDA authorized the workforce to prescribe it, and debate has ensued. 

Rome (N.Y.) Health opened its community pharmacy inside the hospital's new medical center Nov. 14. 

Amid a national shortage of pharmacy technicians, hospital pharmacy teams are forced to get creative when it comes to hiring and retaining enough workers. 

Columbus-based Mount Carmel Health System tapped Amy Dickson, PharmD, to be its regional chief pharmacy officer, effective Nov. 14. 

Days after BQ.1 and BQ.1.1 surpassed BA.5 — the long-standing dominant COVID-19 subvariant — Moderna said its bivalent booster showed "robust neutralizing activity" against BQ.1.1 and had a 15.1-fold increase against BA.4 and BA.5. 

Moderna and Pfizer will soon launch trials to evaluate the long-term risk of myocarditis, or inflammation of the heart muscle, with their COVID-19 vaccines, NBC News reported Nov. 12.